Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Elizabeth Holmes, founder and CEO of Theranos. Photo: Adam Jeffery/CNBC/NBCU Photo Bank via Getty Images
Elizabeth Holmes, the embattled founder and CEO of Theranos, reportedly told shareholders Tuesday that the blood testing start-up is in dire need of funding and at risk of defaulting on a $100 million loan.
The details: In a letter obtained by BuzzFeed News, Holmes said the company had been forced to delay blood testings for the Zika virus after failing to be granted approval for the technology from the FDA. The company had only received $65 million of the loan through installments based on specific progress, she wrote. The Wall Street Journal first reported that the company laid off the majority of its remaining employees to avoid bankruptcy.